Vita Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Vita Therapeutics?

Vita Therapeutics has 6 investors including Cedars Sinai And Solve FSHD.

Q: When was the last funding round for Vita Therapeutics?

Vita Therapeutics closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Vita Therapeutics raised to date?

Vita Therapeutics has raised obfuscated.

Overview

Vita Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Vita Therapeutics

CB Rank

47802

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

Founded

obfuscation

Private

Series B

Baltimore, Maryland, United States

11-50

www.vitatx.com/

Biotechnology

Medical

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Douglas Falk: Co-Founder and CEO
Mahendra Rao: Chief Scientific Officer

Details

Legal Name

Vita Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Douglas Falk, Peter Andersen

About the Company

Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Vita utilizes induced pluripotent stem cell technology to engineer specific cell types designed to replace those that are defective in patients.

Contact Email

info@vita-therapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Vita Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

VTA-100

An autologous cell therapy using gene-corrected induced pluripotent stem cells to repair and replace muscle cells in patients with limb-girdle muscular dystrophy type 2A (LGMD2A).

VTA-120

An autologous cell therapy combining gene correction and iPSC technology to repair and replace muscle cells for treating facioscapulohumeral muscular dystrophy (FSHD).

Research & Development

Vita Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B
obfuscated obfuscation	Series B - Vita Therapeutics	5	obfuscated obfuscation	Cambrian Biopharma, Solve FSHD	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Cedars Sinai	—	Series B - Vita Therapeutics	—
Cedars Sinai	—	Series B - Vita Therapeutics	—
Cedars Sinai	—	Series B - Vita Therapeutics	—
Cedars Sinai	—	Series B - Vita Therapeutics	—
Cedars Sinai	—	Series B - Vita Therapeutics	—